Galmed Pharmaceuticals Ltd. will perform a 1-for-12 reverse share split effective after market close on August 29, 2024, reducing the number of shares from approximately 7,594,668 to about 632,889 shares, with new trading commencing on August 30, 2024. This filing is significant for the company's capital structure.